Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis

Bioactive lipid lysophosphatidic acid species are associated with disease progression in idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive disease with significant mortality. Prognostic biomarkers to identify rapid progressors are urgently needed to improve patient management. Since the lysophosphatidic acid (LPA) pathway has been implicated in lung fibrosis in preclinical models and...

Full description

Bibliographic Details
Main Authors:	Margaret Neighbors, Qingling Li, Sha (Joe) Zhu, Jia Liu, Weng Ruh Wong, Guiquan Jia, Wendy Sandoval, Gaik W. Tew
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Journal of Lipid Research
Subjects:	Lysophosphatidic acid DLCO exacerbation mortality idiopathic pulmonary fibrosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227523000482

Similar Items

Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
by: Qingling Li, et al.
Published: (2021-09-01)

Pulmonary vascular volume is associated with DLCO and fibrotic score in idiopathic pulmonary fibrosis: an observational study
by: Wen-Jui Wu, et al.
Published: (2022-04-01)

Cellular and Molecular Control of Lipid Metabolism in Idiopathic Pulmonary Fibrosis: Clinical Application of the Lysophosphatidic Acid Pathway
by: Yusuke Nakamura, et al.
Published: (2023-02-01)

Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases
by: Shufan Jiang, et al.
Published: (2023-08-01)

Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
by: Bicheng Yang, et al.
Published: (2017-11-01)

Entering, Linked with the Sphinx: Lysophosphatidic Acids Everywhere, All at Once, in the Oral System and Cancer
by: D. Roselyn Cerutis, et al.
Published: (2023-06-01)

Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
by: Yu-Hsuan Lin, et al.
Published: (2021-06-01)

Lysophosphatidic acid and itsreceptors: Role in bronchial asthma pathogenesis
by: O. Yu. Kytikova, et al.
Published: (2024-03-01)

Lysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers
by: Mahdi Rafiyan, et al.
Published: (2022-06-01)

Expression of proteins related to autotaxin–lysophosphatidate signaling in thyroid tumors
by: Eunah Shin, et al.
Published: (2019-08-01)

Lysophosphatidic Acid Receptor 3 Activation Is Involved in the Regulation of Ferroptosis
by: Yi-Xun Huang, et al.
Published: (2024-02-01)

Genetic association between smoking and DLCO in idiopathic pulmonary fibrosis patients
by: Ziheng Yuan, et al.
Published: (2024-04-01)

Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis
by: Keisuke Anan, et al.
Published: (2022-10-01)

Exacerbation of idiopathic pulmonary fibrosis
by: S. N. Avdeev, et al.
Published: (2020-03-01)

Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis
by: Esam H Alhamad, et al.
Published: (2020-01-01)

Regulation of Tumor Immunity by Lysophosphatidic Acid
by: Sue Chin Lee, et al.
Published: (2020-05-01)

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer
by: Sha She, et al.
Published: (2022-06-01)

Development and Validation of Diffuse Idiopathic Pulmonary Neuroendocrine Hyperplasia Diagnostic Criteria
by: Olga Sazonova, MD, MSc, et al.
Published: (2020-11-01)

Dual Role of Lysophosphatidic Acid Receptor 2 (LPA2) in Amyotrophic Lateral Sclerosis
by: Maria Puigdomenech-Poch, et al.
Published: (2021-03-01)

Supplementation of Culture Media with Lysophosphatidic Acid Improves The Follicular Development of Human Ovarian Tissue after Xenotransplantaion into The Back Muscle of γ-Irradiated Mice
by: Zeynab Mohammadi, et al.
Published: (2020-10-01)

Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
by: Elisabetta Balestro, et al.
Published: (2019-10-01)

Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis
by: Miia Kärkkäinen, et al.
Published: (2018-05-01)

The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis
by: Tetsuya Hanaka, et al.
Published: (2019-12-01)

Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer
by: C. Chris Yun
Published: (2019-07-01)

Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: the first case report
by: Kuniaki Hirai, et al.
Published: (2019-01-01)

Lysophosphatidic acid supports the development of vitrified ovarian follicles by decreasing the incidence of cell death: An experimental study
by: Neda Abedpour, et al.
Published: (2022-04-01)

C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosis
by: Chen Tao, et al.
Published: (2023-03-01)

Inhibitors of the Autotaxin-Lysophosphatidic Acid Axis and Their Potential in the Treatment of Interstitial Lung Disease: Current Perspectives
by: Zulfikar S, et al.
Published: (2020-07-01)

Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Toru Arai, et al.
Published: (2023-11-01)

Lysophosphatidic acid stimulates rat uterine contraction in vitro
by: Satoshi NAGASHIMA, et al.
Published: (2023-04-01)

Detection of the Ovarian Cancer Biomarker Lysophosphatidic Acid in Serum
by: Brian De La Franier, et al.
Published: (2020-02-01)

Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders
by: Candide Alioli, et al.
Published: (2022-03-01)

Lysophosphatidic Acid Is a Proinflammatory Stimulus of Renal Tubular Epithelial Cells
by: Christiana Magkrioti, et al.
Published: (2022-07-01)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis
by: Tomoo Kishaba
Published: (2019-03-01)

Study of IPF among patients with gastro-esophageal reflux disease
by: Sami Eldahdouh, et al.
Published: (2017-01-01)

Profiling lysophosphatidic acid levels in plasma from head and neck cancer patients
by: Mariati Abdul Rahman, et al.
Published: (2020-06-01)

Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
by: Pravita Balijepalli, et al.
Published: (2021-08-01)

Coronavirus disease 2019 vaccination‐induced acute exacerbation in idiopathic pulmonary fibrosis
by: Keishi Sugino, et al.
Published: (2022-11-01)

Successful Rescue of Acute Exacerbation of Idiopathic Pulmonary Fibrosis after Surgery for Lung Cancer: Case Report
by: Chuan HUANG, et al.
Published: (2022-05-01)

Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?
by: Ioannis Tomos, et al.
Published: (2023-10-01)